{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:11:37Z","timestamp":1790755897761,"version":"4.1.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,2,1]]},"DOI":"10.1093\/qjmed\/hcg020","type":"journal-article","created":{"date-parts":[[2003,2,15]],"date-time":"2003-02-15T00:05:09Z","timestamp":1045267509000},"page":"155-160","source":"Crossref","is-referenced-by-count":11,"title":["Superiority and equivalence in thrombolytic drugs: an interpretation"],"prefix":"10.1093","volume":"96","author":[{"given":"T.","family":"WALLEY","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["QJM"],"original-title":[],"link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/96\/2\/155\/4425665\/960155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T01:14:30Z","timestamp":1503537270000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article-lookup\/doi\/10.1093\/qjmed\/hcg020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcg020","relation":{},"ISSN":["1460-2393"],"issn-type":[{"value":"1460-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,1]]}}}